AIMode.newsSearch
Live

Designing supramolecular therapies to cross the blood-brain barrier

P

Phys.org

AIMode News Desk · curated summary

1 min readScience

Automated news aggregation. Headlines and summaries are gathered from public feeds; see our editorial standards for sourcing, corrections, and AI-assist disclosure.

A new Northwestern Medicine study has uncovered key molecular design principles that could help supramolecular therapeutics cross the blood-brain barrier, a major challenge for this novel approach to treating neurological disorders.

Advertisement

About this story

This story was aggregated from Phys.org. Headlines, summaries, and links are gathered automatically from public RSS feeds for your convenience.

Read the full story →

For agents:JSON recordOpenAPIWebMCPllms.txt

Advertisement

More in Science

Science

Nanoparticle combines two strategies to speed up the healing of chronic wounds

Researchers at the University of São Paulo (USP) in Ribeirão Preto, Brazil, have developed a nanoparticle that can address the various factors hindering the healing of chronic wounds, which include ulcers associated with diabetes and pressure ulcers common among bedridden individuals. These wounds, which may persist for months or even years, affect about 1% to 2% of the population and represent a significant public health concern because they increase the risk of infection and amputation and significantly impair patients' quality of life.

Phys.org ·